Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441612 | 0.75 | KDM4E (0.31) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL18677022 | 0.71 | MAPT (0.33) | KDM4EMAPT | |
| SCHEMBL19052344 | 0.70 | KDM4E (0.37) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL15746982 | 0.67 | — | — | |
| SCHEMBL6300746 | 0.67 | KDM4E (0.31) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL20827851 | 0.67 | — | — | |
| SCHEMBL17085510 | 0.64 | — | — | |
| SCHEMBL649183 | 0.64 | — | — | |
| SCHEMBL10344203 | 0.63 | MEN1 (0.55) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL1906786 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4167938-B1 | BIODEGRADABLE UV ABSORBERS | BASF SE (DE) | 2025-08-27 | — | — | EP | disclosed |
| WO-2025081381-A1 | NANOPARTICLES CAPABLE OF REALIZING CONTROLLED RELEASE OF CARBON MONOXIDE, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国科学院深圳先进技术研究院 | 2025-04-24 | — | — | WO | disclosed |
| CN-117414347-A | Nanoparticle capable of controllably releasing carbon monoxide and preparation method and application thereof | 中国科学院深圳先进技术研究院 | 2024-01-19 | — | — | CN | disclosed |
| US-20230293411-A1 | BIODEGRADABLE UV ABSORBERS | BASF SE (DE) | 2023-09-21 | — | — | US | disclosed |
| EP-4167938-A1 | BIODEGRADABLE UV ABSORBERS | BASF SE (DE) | 2023-04-26 | — | — | EP | disclosed |
| CN-115916143-A | Biodegradable UV absorbers | 巴斯夫欧洲公司 | 2023-04-04 | — | — | CN | disclosed |
| EP-3479863-B1 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | MALLINCKRODT PHARMACEUTICALS IRELAND LTD (IE) | 2021-11-24 | — | — | EP | disclosed |
| EP-3479863-A1 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | INO Therapeutics LLC (US) | 2019-05-08 | — | — | EP | disclosed |
| EP-2613839-B1 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | INO THERAPEUTICS LLC (US) | 2018-12-12 | — | — | EP | disclosed |
| US-9353092-B2 | Synthesis and use of croconaine compounds | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2016-05-31 | — | — | US | disclosed |
| US-20150005501-A1 | SYNTHESIS AND USE OF CROCONAINE COMPOUNDS | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2015-01-01 | — | — | US | disclosed |
| EP-2613839-A1 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | Ikaria, Inc. (US) | 2013-07-17 | — | — | EP | disclosed |
| WO-2012034089-A1 | COMPOSITIONS, METHODS AND ARTICLES CONCERNING PHARMACEUTICAL NITRIC OXIDE AND CONTROLLED PATIENT DELIVERY SYSTEMS THEREOF | IKARIA, INC. (US) | 2012-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150005501-A1 | SYNTHESIS AND USE OF CROCONAINE COMPOUNDS | AADAT, CROCC, TNNT2 | KDM4E 696/4885MEN1 4133/4885ALDH1A1 287/4885 |
| US-20230293411-A1 | BIODEGRADABLE UV ABSORBERS | ERCC4, ERCC1, UNG | KDM4E 2578/4885MEN1 1093/4885ALDH1A1 65/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.